Table 1.
Characteristics of patients with colorectal cancer and liver metastases undergoing SIR therapy
| Median | Range | |
|---|---|---|
| Age | 62.6 years | 35.3 - 77.9 years |
| Time to SIRT after primary diagnosis | 25 months | 6-140 |
| Number | Percentage (%) | |
| Patients | 49 | 100 |
| Gender | ||
| Female | 16 | 32.7 |
| Male | 33 | 67.3 |
| Localisation of primary tumor | ||
| Colon | 11 | 22.5 |
| Sigma | 22 | 44.0 |
| Rectum | 16 | 32.5 |
| Chemotherapies before SIRT | ||
| FOLFOX | 42 | 85.7 |
| FOLFIRI | 47 | 95.9 |
| Therapy response | ||
| REM | 9 | 18.4 |
| SD | 5 | 10.2 |
| PD | 35 | 71.4 |
| Progression defining | ||
| liver metastases | 19 | 54.3 |
| extrahepatic manifestation | 6 | 17.1 |
| deceased | 10 | 28.6 |
| One year survival* | ||
| Yes | 22 | 45.8 |
| No | 26 | 54.2 |
| Median | 95% Conf. Interval | |
| Overall survival | 8.8 months | 5.1-18.1 |
* one patient lost to follow-up